Lack of correlation between non-labile iron parameters, total carbonyl and malondialdehyde in major thalassemia

Journal of Clinical Biochemistry and Nutrition

Volumn 55, Issue 3, 2014, Pages 203-206

  Al Hakeim, Hussein Kadhem ^a   Auda, Furqan Muein ^a   Ali, Basim Muhammed ^a  

^a UNIVERSITY OF KUFA   (Iraq)

Author keywords

Malondialdehyde; Non labile iron; Thalassemia; Total carbonyl

Indexed keywords

CARBONYL DERIVATIVE; DEFEROXAMINE MESYLATE; IRON; LIPID; MALONALDEHYDE; PROTEIN; TRANSFERRIN;

ARTICLE; BLOOD LEVEL; CHELATION THERAPY; CHILD; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ERYTHROCYTE TRANSFUSION; HIGH RISK PATIENT; HUMAN; IRAQI; IRON BINDING CAPACITY; IRON BLOOD LEVEL; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; OXIDATION; OXIDATIVE STRESS; PROTEIN METABOLISM; THALASSEMIA MAJOR; VULNERABLE POPULATION;

EID: 84908611694     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.14-24     Document Type: Article

References (34)

1. Hassan MK, Taha JY, Al-Naama LM, Widad NM, Jasim SN. Frequency of haemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in Basra. East Mediterr Health J 2003; 9: 45-54.
2. Al-Allawi NA, Jubrael JM, Hughson M. Molecular characterization of beta-thalassemia in the Dohuk region of Iraq. Hemoglobin 2006; 30: 479-486.
3. Abdulzahra MS, Al-Hakeim HK, Ridha MM. Study of the effect of iron overload on the function of endocrine glands in male thalassemia patients. Asian J Transfus Sci 2011; 5: 127-131.
4. Ponka P. Recent advances in cellular iron metabolism. J Trace Elem Exp Med 2003; 16: 201-217.
5. Nair V, O'Neil CL, Wang PG. Malondialdehyde. In: e-EROS Encyclopedia of Reagents for Organic Synthesis. New York: John Wiley & Sons, 2008; 832.
6. Farmer EE, Davoine C. Reactive electrophile species. Curr Opin Plant Biol 2007; 10: 380-386.
7. Del Rio D, Stewart AJ, Pellegrini N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis 2005; 4: 316-328.
8. Kadiiska MB, Gladen BC, Baird DD, et al. Biomarkers of oxidative stress study III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning. Free Radic Biol Med 2005; 38: 711-718.
9. Petersen DR, Doorn JA. Reactions of 4-hydroxynonenal with proteins and cellular targets. Free Radic Biol Med 2004; 37: 937-945.
10. Artiss JD, Vinogradov S, Zak B. Spectrophotometric study of several sensitive reagents for serum iron. Clin Biochem 1981; 14: 311-315.
11. Iron Panel of the International Committee for Standardization in Hematology. The measurement of total and unsaturated iron-binding capacity in serum. Br J Haematol 1978; 38: 281-290.
12. Rayssiguier Y, Mbega JD, Durlach V, et al. Mgnesium and blood pressure. I. Animal studies. Book of abstracts. VIth International Mg Symposium abstracts. Indore, India, Dec 2-6, 1991.
13. Freeman V, Arneson W. Hemoglobin production, disorders, and testing. In: Anderson W, Brickell J, eds. Clinical Chemistry: A Laboratory Prospective. Philadelphia, FA Daves Co., 2007; 185.
14. Morgan EH. Transferrin. In: Haeberli A, ed. Human Protein Data, Part B. Weinheim, Wiley-VCH, 1992; 291.
15. Livrea MA, Tesoriere L, Pintaudi AM, et al. Oxidative stress and antioxidant status in beta-thalassemia major: iron overload and depletion of lipid-soluble antioxidants. Blood 1996; 88: 3608-3614.
16. Naithani R, Chandra J, Bhattacharjee J, Verma P, Narayan S. Peroxidative stress and antioxidant enzymes in children with beta-thalassemia major. Pediatr Blood Cancer 2006; 46: 780-785.
17. Dasgupta S, Dasgupta A, Mukhopadhayay T, et al. Serum uric acid: an early indicator of oxidative stress in beta thalassemia population. Mymensingh Med J 2013; 22: 567-573.
18. Shizukuda Y, Bolan CD, Nguyen T, et al. Oxidative stress in asymptomatic subjects with hereditary hemochromatosis. Am J Hematol 2007; 82: 249-250.
19. Hershko C. Pathogenesis and management of iron toxicity in thalassemia. Ann N Y Acad Sci 2010; 1202: 1-9.
20. Yates AM, Mortier NA, Hyde KS, Hankins JS, Ware RE. The diagnostic dilemma of congenital unstable hemoglobinopathies. Pediatr Blood Cancer 2010; 55: 1393-1395.
21. Noori NM, Mehralizadeh S. Echocardiographic evaluation of systolic and diastolic heart function in patients suffering from beta-thalassemia major aged 5-10 years at the Zahedan Research Center for Children and Adolescent Health. Anadolu Kardiyol Derg 2010; 10: 150-153.
22. Larade K, Storey KB. Accumulation and translation of ferritin heavy chain transcripts following anoxia exposure in a marine invertebrate. J Exp Biol 2004; 207: 1353-1360.
23. Walter PB, Fung EB, Killilea DW, et al. Oxidative stress and inflammation in iron-overloaded patients with β-thalassaemia or sickle cell disease. Br J Haematol 2006; 135: 254-263.
24. Cighetti G, Duca L, Bortone L, et al. Oxidative status and malondialdehyde in beta-thalassemia patients. Eur J Clin Invest 2002; 32: 55-60.
25. Halliwell B, Gutteridge JM. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 1990; 186: 15-85.
26. Fibach E, Rachmilewitz EA. The role of antioxidants and iron chelators in the treatment of oxidative stress in thalassemia. Ann N Y Acad Sci 2010; 1202: 10-16.
27. Meerang M, Nair J, Sirankapracha P, et al. Accumulation of lipid peroxidation-derived DNA lesions in iron-overloaded thalassemic mouse livers: comparison with levels in the lymphocytes of thalassemia patients. Int J Cancer 2009; 125: 759-766.
28. Chakraborty I, Mitra S, Gachhui R, Kar M. Non-haem iron-mediated oxidative stress in haemoglobin E beta-thalassaemia. Ann Acad Med Singapore 2010; 39: 13-16.
29. Kadiiska MB, Gladen BC, Baird DD, et al. Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med 2005; 38: 698-710.
30. Vichinsky EP, Butensky E, Fung E, et al. Comparison of organ dysfunction in transfused patients with SCD or B thalassemia. Am J Hematol 2005; 80: 70-74.
31. Scott MD, van den Berg JJ, Repka T, et al. Effect of excess alpha-hemoglobin chains on cellular and membrane oxidation in model beta-thalassemic erythrocytes. J Clin Invest 1993; 91: 1706-1712.
32. Zainal TA, Weindruch R, Szweda LI, Oberley TD. Localization of 4- hydroxy-2-nonenal-modified proteins in kidney following iron overload. Free Radic Biol Med 1999; 26: 1181-1193.
33. 2+-citrate. An Acad Bras Cienc 2006; 78: 505-514.
34. Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 2001; 30: 1191-1212.